Literature DB >> 17303606

A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients.

N Assy, P C Adams, P Myers, V Simon, C N Ghent.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17303606      PMCID： PMC1856762          DOI： 10.1136/gut.2006.107862

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

Review 1.  Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

Authors:  K N Lazaridis; G J Gores; K D Lindor
Journal:  J Hepatol       Date:  2001-07       Impact factor: 25.083

2.  Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients.

Authors:  H Persson; S Friman; T Scherstén; J Svanvik; I Karlberg
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

3.  Recurrent autoimmune hepatitis after orthotopic liver transplantation.

Authors:  A González-Koch; A J Czaja; H A Carpenter; S K Roberts; M R Charlton; M K Porayko; C B Rosen; R H Wiesner
Journal:  Liver Transpl       Date:  2001-04       Impact factor: 5.799

4.  Immunomodulatory effects of ursodeoxycholic acid on immune responses.

Authors:  M Yoshikawa; T Tsujii; K Matsumura; J Yamao; Y Matsumura; R Kubo; H Fukui; S Ishizaka
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

5.  Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?

Authors:  Georges-Philippe Pageaux; Michael Bismuth; Pascal Perney; Valérie Costes; Samir Jaber; Pascal Possoz; Jean-Michel Fabre; Francis Navarro; Pierre Blanc; Jacques Domergue; Jean-Jacques Eledjam; Dominique Larrey
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

6.  Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression.

Authors:  José A Pons; José Yélamos; Pablo Ramírez; María Oliver-Bonet; Alicia Sánchez; Manolo Rodríguez-Gago; Joaquima Navarro; Juan Bermejo; Ricardo Robles; Pascual Parrilla
Journal:  Transplantation       Date:  2003-04-15       Impact factor: 4.939

7.  Weaning of immunosuppression in long-term liver transplant recipients.

Authors:  H C Ramos; J Reyes; K Abu-Elmagd; A Zeevi; N Reinsmoen; A Tzakis; A J Demetris; J J Fung; B Flynn; J McMichael
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

8.  Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes.

Authors:  Y Calmus; J Guechot; P Podevin; M T Bonnefis; J Giboudeau; R Poupon
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

9.  Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.

Authors:  W J Sandborn; J E Hay; M K Porayko; G J Gores; J L Steers; R A Krom; R H Wiesner
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425
  9 in total
  4 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

Review 2.  Organ-specific differences in achieving tolerance.

Authors:  Maria Lucia L Madariaga; Daniel Kreisel; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

Review 3.  Liver organoids: from basic research to therapeutic applications.

Authors:  Nicole Prior; Patricia Inacio; Meritxell Huch
Journal:  Gut       Date:  2019-07-12       Impact factor: 23.059

Review 4.  Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application.

Authors:  Naoki Tanimine; Masahiro Ohira; Hiroyuki Tahara; Kentaro Ide; Yuka Tanaka; Takashi Onoe; Hideki Ohdan
Journal:  Front Immunol       Date:  2020-07-31       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.